PLYMOUTH MEETING, Pa., Dec. 12 /PRNewswire-FirstCall/ -- Genaera Corporation today announced that Jack Armstrong, President and Chief Executive Officer of Genaera, is scheduled to present at the 2007 RBC Capital Markets Healthcare Conference. The presentation is part of an RBC Capital Markets' panel discussion of diabetes and obesity, entitled, "The Pharmaceutical Sweet Spot: Diabetes & Obesity," and will take place in New York on Thursday, December 13 at 10:00 a.m. ET.
www.wsw.com/webcast/rbc84qpanel23
About Genaera
Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a Phase 1 trial in obesity. In addition, Genaera has a value- driven, fully out-licensed partnership with MedImmune, Inc. for a second core program that is presently undergoing Phase 2 clinical testing in asthma. Genaera is committed to directing resources to its core program and the aggressive clinical development of its key assets to build stockholder value. For further information, please see our website at http://www.genaera.com.
CONTACT: Genaera Corporation, Investor Relations, +1-610-941-5675; or
Media, Susan Neath of Porter Novelli Life Sciences, +1-619-849-6007,
sneath@pnlifesciences.com, for Genaera Corporation
Web site: http://www.genaera.com/
